Search Results - "Duan, Xian‐Zhi"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2
  3. 3

    Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study by Zhao, Xue-Lian, Zhao, Shuang, Xia, Chang-Fa, Hu, Shang-Ying, Duan, Xian-Zhi, Liu, Zhi-Hua, Wang, Yue-Yun, You, Ting-Ting, Gao, Meng, Qiao, You-Lin, Basu, Partha, Zhao, Fang-Hui

    Published in BMC medicine (17-04-2023)
    “…Self-sampling HPV test and thermal ablation are effective tools to increase screening coverage and treatment compliance for accelerating cervical cancer…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Expression of glucose transporter protein 1 and p63 in serous ovarian tumor by Cai, Yu, Zhai, Jian-jun, Feng, Bi-bo, Duan, Xian-zhi, He, Xiao-jin

    “…Aim It has been shown that glycolytic metabolism is increased in malignant cells. Cancer cell growth is an energy‐related process supported by an increased…”
    Get full text
    Journal Article
  6. 6

    Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China by Wang, Margaret Z, Feng, Rui-mei, Wang, Shaoming, Duan, Xian-zhi, Li, Dong, Zhang, Xun, Mu, Rong, Qiao, Youlin, Smith, Jennifer S

    Published in Sexually transmitted diseases (01-08-2019)
    “…BACKGROUNDWorld Health Organization guidelines recommend screening with human papillomavirus (HPV) testing followed by either treatment of all HPV-positives,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    CLINICAL PERFORMANCE OF HPV TESTING AND VIA IN PRIMARY, COMBINATION, AND SEQUENTIAL CERVICAL CANCER SCREENING IN CHINA by Wang, Margaret Z., Feng, Rui-mei, Wang, Shaoming, Duan, Xian-zhi, Li, Dong, Zhang, Xun, Mu, Rong, Qiao, Youlin, Smith, Jennifer S.

    Published in Sexually transmitted diseases (01-08-2019)
    “…Sequential algorithms of primary HPV with VIA triage did not have better clinical performance than primary HPV or primary VIA alone in low-resource settings…”
    Get full text
    Journal Article
  12. 12

    CLINICAL PERFORMANCE OF HPV TESTING AND VIA IN PRIMARY, COMBINATION, AND SEQUENTIAL CERVICAL CANCER SCREENING IN CHINA by Wang, Margaret Z, Feng, Rui-mei, Wang, Shaoming, Duan, Xian-zhi, Li, Dong, Zhang, Xun, Mu, Rong, Qiao, Youlin, Smith, Jennifer S

    Published in Sexually transmitted diseases (14-06-2019)
    “…BACKGROUNDWHO guidelines recommend screening with HPV testing followed by either treatment of all HPV positives, or by visual inspection (VIA) for triage to…”
    Get full text
    Journal Article
  13. 13

    Human papillomavirus genotype distribution in invasive squamous cell carcinoma of the uterine cervix in Mongolian women in inner Mongolia autonomy region by Yuan, Dan-Dan, Cui, Jian-Feng, Liu, Bin, Liu, Xin-Fu, Zhang, Xun, Cen, Yao, Wang, Xiu-Rong, Chen, Wen, Qiao, You-Lin, Duan, Xian-Zhi

    “…To investigate the prevalence of human papillomavirus (HPV) and the HPV genotype distribution in invasive squamous cell carcinoma of the uterine cervix in the…”
    Get more information
    Journal Article
  14. 14

    Oxidation behavior of ternary Fe-15Cu-5A1 and Fe-85Cu-5A1 alloys in pure oxygen at 900 deg C by Xiang, Jun-Huai, Niu, Yan, Duan, Xian-Zhi

    “…The oxidation of two two-phase ternary Fe-Cu-Al alloys containing about 5%(mole fraction) aluminium, one Fe-rich and one Cu-rich, has been studied at 900 deg C…”
    Get full text
    Journal Article
  15. 15

    Isothermal nanocrystallization behavior of bulk metallic glass composites in supercooled liquid region by Zhang, Xiang-Yun, Yuan, Zi-Zhou, Feng, Xue-Lei, Cui, Li-Zhi, Li, Duan-Xian

    Published in Rare metals (01-11-2017)
    “…Bulk metallic glass composites (BMGCs) reinforced by micro- (spherical size of about 10 gin) and nano-sized (20-50 nm) A13Zr crystals were synthesized by…”
    Get full text
    Journal Article
  16. 16

    Delayed introduction of immunosuppressive regimens in critically ill patients after liver transplantation by Luo, Ying, Ji, Wen-Bin, Duan, Wei-Dong, Shi, Xian-Jie, Zhao, Zhi-Ming

    “…BACKGROUND: The manipulation of immunosuppression therapy remains challenging in patients who develop infectious diseases or multiple organ dysfunction after…”
    Get full text
    Journal Article